News & Events

Using single-cell technologies, Maike Sander and colleagues have observed a shift in the relative abundance of the two subtypes of pancreatic beta cells as type 2 diabetes unfolds. This knowledge could be leveraged to find novel drugs, they report in “Nature Genetics.”

Cancer cells are capable of escaping chemotherapy and radiotherapy by activating a signaling pathway that prevents them from dying. Researchers led by Claus Scheidereit at the Max Delbrück Center have now described in Cell Chemical Biology two new compounds that block this escape route.

No science-remote phase-out plan for animal research in Europe – the EU-LIFE research alliance, which includes the Max Delbrück Center, welcomes the EU Commission's response to the European citizens' initiative "Save Cruelty Free Cosmetics".

The stem cell therapy developed by MyoPax, a spin-off from the Max Delbrück Center and Charité, could soon be helping children with previously incurable muscle diseases thanks to an accelerated approval process. The necessary clinical trial will start in the fall.

The Berlin competition "Who cycles the most?" has come to a close, with the Max Delbrück Center and the facilities of Campus Buch took third-place. Approximately nine percent of all employees from administration and science participated in the competition, taking to their saddles.

Researchers at BIH and the Max Delbrück Center have developed a new approach for vaccines against coronaviruses using modified spike proteins with lower binding affinity. This method could make vaccinations more effective, the team writes in the "European Journal of Immunology".

Since 2018, Jutta Kramm has headed the communications department at the Max Delbrück Center, and her team is also responsible for “Insights”. Now, the seasoned journalist shares a reading recommendation: a fascinating and moving book about a wondrous creature, the eel, and the big questions of life.

The Arl8b protein provides new insights into the mechanisms underlying Alzheimer’s disease. It also has the potential to function as a diagnostic marker. The scientists behind this discovery, a team led by Erich Wanker from the Max Delbrück Center, have published their findings in “Genome Medicine”.

RNA molecules travel long distances through nerve cells. To reach their destination, they need one thing more than any other – a long life – as a research team led by Marina Chekulaeva from MDC-BIMSB reports in the journal “Molecular Cell.”